KMI
51
5
AFL
53
-2
NVDA
60
4
IBM
71
-3
AVB
60
-4
CAT
62
4
WRK
72
3
NWSA
82
-2
CMA
53
-5
CCI
36
3
IVZ
55
2
NAVI
52
2
CRM
62
3
RRC
65
3
UHS
54
2
FSLR
52
8
HSY
38
-2
EQIX
52
-2
T
45
-2
SEE
36
3
KMI
51
5
AFL
53
-2
NVDA
60
4
IBM
71
-3
AVB
60
-4
CAT
62
4
WRK
72
3
NWSA
82
-2
CMA
53
-5
CCI
36
3
IVZ
55
2
NAVI
52
2
CRM
62
3
RRC
65
3
UHS
54
2
FSLR
52
8
HSY
38
-2
EQIX
52
-2
T
45
-2
SEE
36
3
Financhill
Back

Ultragenyx Pharmaceutical Vs. PTC Therapeutics Industry Stock Comparison

Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
40.21
Seasonality Move:
-7.08%
Sell
35

PTCT
PTC Therapeutics

Last Price:
30.99
Seasonality Move:
8.11%
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.21. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $31.00. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight selling pressure.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $31.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 47.42 Sell
Chaikin Money Flow: -311343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.94 - 42.12) Sell
Bollinger Bands (100): (40.54 - 48.68) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 38.05 Sell
Chaikin Money Flow: 242921 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.07 - 37.67) Sell
Bollinger Bands (100): (26.88 - 35.22) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.57 Sell
20-day SMA: 40.71 Sell
50-day SMA: 41.31 Sell
200-day SMA: 42.48 Sell
8-day EMA: 40.56 Sell
20-day EMA: 40.59 Sell
50-day EMA: 41.63 Sell
200-day EMA: 43.23 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.97 Sell
20-day SMA: 35.08 Sell
50-day SMA: 34.11 Sell
200-day SMA: 27.6 Buy
8-day EMA: 32.46 Sell
20-day EMA: 34.04 Sell
50-day EMA: 33.6 Sell
200-day EMA: 31.79 Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):